ABEO Stock Analysis: Buy, Sell, or Hold?
ABEO - Abeona Therapeutics Inc. Common Stock
$7.01
0.03 (0.43%)
▲
5d:
+11.09%
30d:
+30.78%
90d:
+42.77%
HOLD
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 13, 2026
29d
Get Alerted When ABEO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called ABEO this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: ABEO is 8.2% above its trading range ($6.48). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: ABEO is 8.2% above its trading range ($6.48). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$8.52
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$5.29
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ABEO is currently trading at $7.01, which is considered extended relative to its 30-day fair value range of $5.41 to $6.48. From a valuation perspective, the stock is trading at a premium (Forward PE: 24.4) compared to its historical average (21.2). At these levels, the market is pricing in 4.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ABEO is in a uptrend. Immediate support is located at $5.51, while resistance sits at $7.25.
Market Sentiment: ABEO has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $19.71 (+181.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ABEO is in a uptrend. Immediate support is located at $5.51, while resistance sits at $7.25.
Market Sentiment: ABEO has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $19.71 (+181.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$5.41 -
$6.48
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
56.2%
All Signals
- BEARISH: Price extended above range (+8.2% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 181.2% below Wall St target ($19.71)
- NEUTRAL: Trading at premium valuation - market expects 4.9% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$5.41 -
$6.48
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$5.52
Resistance Level
$7.25
Current Trend
Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
24.45
Wall Street Target
$19.71
(+181.2%)
Revenue Growth (YoY)
-100.0%
Profit Margin
454.9%
Valuation Premium vs History
+4.9% premium
PE vs Historical
24.5 vs 21.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.9%
(market-implied from PE analysis)
1-Year Target
$7.35
(+5%)
2-Year Target
$7.71
(+10%)
3-Year Target
$8.09
(+15%)
3-Yr Target (if PE normalizes)
(PE: 24→21)
PE COMPRESSION
$7.02
(+0%)
Earnings growth offset by PE compression
📈
Valuation based on Current Earnings
Trailing PE: 7.35 | Current EPS (TTM): $0.95
Bull Case
$3.84
(-45%)
Analyst growth -50.0%, PE expands to 8.1
Base Case
$3.49
(-50%)
Market implied -50.0%, PE stable at 7.4
Bear Case
$4.75
(-32%)
Severe decline -20.0%, PE contracts to 6.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 14, 2026 6:14 AM ET
Data refreshes hourly during market hours. Next update: 7:14 AM
Data refreshes hourly during market hours. Next update: 7:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABEO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Eric Crombez
SELL
16284 shares
2026-02-02
Leila Alland
SELL
18065 shares
2026-02-02
Mark Alvino
SELL
2000 shares
2026-02-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$413 | 54 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 61 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 55 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
